In silico Analysis on the Possible Role of Mitochondria in Ferroptosis by Lőrincz, Tamás & Szarka, András
370|https://doi.org/10.3311/PPch.12571Creative Commons Attribution b
Periodica Polytechnica Chemical Engineering, 62(4), pp. 370–378, 2018
Cite this article as: Lőrincz, T., Szarka, A. "In silico Analysis on the Possible Role of Mitochondria in Ferroptosis", Periodica Polytechnica Chemical 
Engineering, 62(4), pp. 370–378, 2018. https://doi.org/10.3311/PPch.12571
In silico Analysis on the Possible Role of Mitochondria in 
Ferroptosis
Tamás Lőrincz1, András Szarka1*
1 Department of Applied Biotechnology and Food Science, Faculty of Chemical Technology and Biotechnology, 
Budapest University of Technology and Economics, H-1521 Budapest, P.O.B. 91, Hungary
* Corresponding author, e-mail: szarka@mail.bme.hu
Received: 24 May 2018, Accepted: 28 June 2018, Published online: 07 August 2018
Abstract
The lipid peroxide scavenger enzyme glutathione peroxidase 4 (GPX4) and its cofactor glutathione play a crucial role in the recently 
described programmed cell death, ferroptosis. Since mitochondria are the major sources of reactive oxygen species in mammalian 
cells the linkage between mitochondria, mitochondrial ROS generation and ferroptosis emerged quite early. As a result of alternative 
splicing human GPX4 has three different isoforms: long form (lGPX4), short form (sGPX4) and nuclear form (nGPX4) of which sGPX4 
was found essential. To clarify the potential role of mitochondria in ferroptosis the localization of both the long and short versions 
of GPX4 and the only verified glutathione transport protein SLC25A11 was investigated by different in silico tools. Targeting of lGPX4 
and sGPX4 to multiple organelles is possible as a number of rule- and neural network-based algorithms showed concordant results 
to specific pathways. Hence the mitochondrial localization of both isoforms on the base of in silico prediction is possible. Since sGPX4 
was found in multiple organelles and non-canonical import pathways are presumable we also evaluated the previously used in silico 
methods in predicting the localization of a chimeric signal containing peptide CYP2B1 as well as a solely mitochondrial targeted 
CYP27A1. Our in silico results showed that only the CELLO prediction tool ranked mitochondrial import with meaningful possibility 
based on neighboring sequence composition. Summarily the possible mitochondrial localization of both long and short isoforms of 
GPX4 and the glutathione transporter SLC25A11 support the assumption that mitochondria play an important role in the pathways 
leading to ferroptosis.
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1 Introduction
The water-soluble tripeptide glutathione (GSH) is exclu-
sively synthesized in the cytosol where it can be found in 
millimolar range [1-3]. As a cofactor of glutathione perox-
idase it quenches hydrogen-peroxide and repairs lipid oxi-
dation, scavenges reactive nitrogen species (RNS), the ratio 
of its reduced/oxidized form (GSH/GSSG) serves as a sen-
sitive factor of cellular redox state, hence it mediates redox 
signaling, furthermore it conjugates with drugs and xeno-
biotics under the catalysis of glutathione S-transferases 
(GSTs) [4]. Looking at this list of important functions it is 
not surprising that extensive GSH depletion was involved 
in different cell deaths such as apoptosis, necroptosis and 
autophagy [5-8]. Beyond these cell death types GSH and 
GSH depletion plays a crucial role in a recently described 
novel programmed cell death, ferroptosis. Ferroptosis 
has been induced (and described) for the first time by the 
addition of the small molecule erastin to oncogenic RAS-
mutant cell lines [9, 10]. Erastin treatment causes a marked 
depletion in the GSH content by the inhibition of the cys-
tine/glutamate antiporter. GSH depletion by erastin has 
clearly been necessary for its lethality since ferroptotic cell 
death could be prevented by the supplementation of the 
culture medium with GSH or N-acetylcysteine [11]. The 
further important feature of ferroptotic cell death was the 
increased levels of lipid hydroperoxides [11]. The genera-
tion of lipid ROS and the induction of ferroptosis could also 
be observed by the direct inhibition or by the knockdown 
of GPX4 [11]. On the base of these observations ferroptosis 
inducers (FIN) have been classified into two classes: type I 
agents (e.g. erastin) that involve GSH depletion and type II 
agents (e.g. RSL3, RSL5, FIN56, FINO2) that trigger fer-
roptosis through inhibition of GPX4 [12]. RSL3 directly 
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inactivates GPX4, FIN56 accelerates the specific degrada-
tion of GPX4 [13], while the organic peroxide FINO2 ini-
tiates lipid peroxidation and iron oxidation [14]. Erastin or 
glutamate inactivates GPX4 indirectly through the inhi-
bition of the cystine/glutamate antiporter, causing subse-
quent cystine and GSH depletion and reduced GPX4 activ-
ity [9, 10]. GPX4 is a GSH dependent seleno-protein with 
the function to eliminate lipid peroxides.  Human GPX4 is 
a functional monomer and is said to have three isoforms 
produced by alternative splicing: lGPX4 (long form, also 
called mitochondrial), sGPX4 (short form, also called 
cytosolic) and nGPX4 (nuclear form). lGPX4 is synthe-
tized from the first start codon and thus, as opposed to 
sGPX4 contains an extra 27 amino acid sequence at the 
N-terminal, which was described to participate in the 
mitochondrial import of lGPX4 [15]. Both start codons 
are located on the first exon of the GPX4 gene and it is 
still debated whether the expression is regulated on a tran-
scriptional or translational level [16].
In an experiment with transgenic mice where either 
lGPX4 or sGPX4 was overexpressed, it was found that 
sGPX4 - albeit not having a mitochondrial targeting prese-
quence - was found to localize in mitochondria and in 
other organelles as well of somatic tissue [17]. It was also 
found that sGPX4 but not lGPX4 was able to rescue the 
lethal knockout of the GPX4 gene and it provided pro-
tection against apoptosis induced by diquat [17]. On the 
behalf of the other isoform lGPX4 was found to be mainly 
expressed in testis with a role in male fertility [17].
nGPX4 is synthetized from an alternative exon which 
codes for an arginine rich nuclear insertion sequence show-
ing high similarity to other known import signals [18]. As 
it was found, nGPX4 is primarily expressed during late 
spermatogenesis where it is the only seleno-protein pres-
ent in the spermatid nuclei and its’ reduction in expression 
resulted in aberrant chromatin condensation and elevation 
in oxidative damage to DNA [18]. However as the knock-
out of nGPX4 in mice - as opposed to the deletion of the 
full GPX4 gene which results in early embryonic lethality- 
did not result in infertility or any major lesions [19] its’ 
biological significance is still investigated.
Mitochondria lay in the centre of cellular oxidative 
metabolism and are the major intracellular ROS source of 
most human cell types. Mitochondrial ROS are continu-
ously generated as a by-product of oxidative phosphory-
lation and linked to cellular degeneration. ROS derived 
from mitochondria may lead to oxidative damage of bio-
molecules that promote cell death [20]. Thus the linkage 
between mitochondria, mitochondrial ROS generation 
and ferroptosis has emerged quite early. This assumption 
was strengthened by the knockdown of VDAC3 that sup-
pressed both the erastin and RSL5-induced cell death [21]. 
However in a later study - on the contrary of the mito-
chondrial localization of the two erastin targets, VDAC2 
and VDAC3 - no increase in MitoSOX-sensitive mito-
chondrial ROS production could be observed due to eras-
tin-treatment [10]. Furthermore, similar ROS accumula-
tion and cell death could be provoked by erastin and RSL3 
in Rho0 cells lacking a functional mitochondrial electron 
transfer chain (ETC), as in the wild type (with functional 
mitochondrial ETC). These later observations disputed the 
role of mitochondria in the mechanism of ferroptosis [10]. 
However in the same study in an attempt to identify the 
genetic basis of erastin sensitivity a set of proteins local-
ized in mitochondria were targeted through RNA silenc-
ing and among others, two genes (acyl-CoA synthetase 
family member 2 - ACSF2 - and citrate synthase - CS) 
involved in mitochondrial fatty acid metabolism were 
identified [10]. In a very recent study lipid peroxidation, 
enhanced mitochondrial fragmentation, loss of mitochon-
drial membrane potential, and reduced mitochondrial res-
piration was induced by RSL3. Beyond the well-known 
ferroptosis inhibitors, such as deferoxamine, ferrosta-
tin-1 and liproxstatin-1 the knockout of Bid and the BID 
inhibitor BI-6c9 could protect the cells against the tox-
icity of RSL3. The mitochondria-targeted ROS scavenger 
mitoquinone - despite the significant loss of GPX4 activity 
and the associated significant lipid peroxidation could also 
preserve the mitochondrial function, and cell viability 
[22]. Specific ferroptosis inhibitors - ferrostatin-1 and lip-
roxstatin-1 - are known to alleviate cell demise by block-
age of upstream processes to ROS production and lipid 
peroxidation. As of the arylalkylamine structure of fer-
rostain-1 a potential direct antioxidant function through 
reductive mechanism was suggested by Skouta et al. [23], 
by which it could inhibit oxidative damage to membrane 
lipids and thus cell death. All these observations high-
lighted the potential role of mitochondria (their function 
and integrity) in the mechanism of ferroptosis. The role 
of mitochondria in the generation of ROS is indisputable. 
However, the role of GPX4 in the elimination of lipid ROS 
in mitochondria has not been fully elucidated yet.
To clarify this role the localization of both the long and 
short version of GPX4 and the only verified GSH trans-
port protein SLC25A11 [24] was investigated by different 
in silico tools.
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2 Materials and methods
2.1 Protein sequences
The sequences of both human GPX4 isoforms (Uniprot 
identifiers: lGPX4: P36969; sGPX4: P36969-2), human 
CYP27A1 (Uniprot identifier: Q02318), rat CYP2B1 
(Uniprot identifier: P00176) and human 2-oxoglutarate/
malate carrier protein SLC25A11 (Uniprot identifier: 
Q6IBH0) were retrieved from the Uniprot database (http://
www.uniprot.org/).
2.2 Prediction tools
The subcellular localization of proteins (GPX4, CYP27A1, 
CYP2B1 and SLC25A11) was predicted by an in silico 
analysis using eight different prediction software:
• Target P: http://www.cbs.dtu.dk/services/TargetP/ [25] 
• Mitoprot II: http://ihg.gsf.de/ihg/mitoprot.html [26] 
• Predotar: https://urgi.versailles.inra.fr/predotar/pre-
dotar.html [27] 
• Psort II: http://psort.hgc.jp/form2.html [28]
• iPSORT: http://ipsort.hgc.jp/index.html [29] 
• MultiLoc/TargetLoc: http://abi.inf.uni-tuebingen.de/
Services/MultiLoc/ [30]
• ngLOC: http://genome.unmc.edu/ngLOC/index.html 
[31] 
• YLoc: http://abi.inf.uni-tuebingen.de/Services/
YLoc/webloc.cgi [32] 
• CELLO v2.5: http://cello.life.nctu.edu.tw/ [33] 
The analyses were done in May of 2018.
3 Results and discussion
Mitochondria play a central role in cellular bioenergetics, 
ROS homeostasis, and in various cell death pathways as in 
apoptosis and necroptosis [34, 35]. Therefore, it is not sur-
prising that the role of mitochondria is continuously inves-
tigated in a cell death pathway which has features such as 
oxidative damage to lipid structures, the involvement of 
glutathione dependent antioxidant enzymes and the bio-
synthesis of specific lipid moieties.
As previous results indicated the differential localiza-
tion of GPX4 isoforms had a profound impact on surviv-
ability and cell function, thus we sought to investigate the 
subcellular localization of the two physiologically most 
relevant isoforms lGPX4 and sGPX4 with the aid of in sil-
ico techniques.
lGPX4 differs from sGPX4 by the N-terminal prese-
quence which according to our results using the Mitoprot 
algorithm shows strong mitochondrial localization (Table 1). 
Mitoprot uses a rule-based method to identify N-terminal 
mitochondrial import signal sequences [26], while Predotar 
and TargetP use a trained neural network [25, 27]. 
It is interesting to note that the neural network based 
algorithms rank endoplasmic reticulum import pathway 
highly: TargetP calculated some degree of mitochon-
drial localization, but processing of the lGPX4 peptide 
through the secretory pathway (SP) was considered to be 
more than 3 times as probable while ER localization cal-
culated by Predotar was almost as probable as mitochon-
drial (Table 1). This result was also supported by PSORT 
II and CELLO two rule-based algorithms as extracellu-
lar localization was calculated as most probable based 
on the N-peptide and neighboring sequence composition 
(Table 1). Interestingly the N-terminal signal was iden-
tified by an extension of PSORT II named iPSORT but 
based on the average net charge and pattern it was calcu-
lated as non-mitochondrial (data not shown).
Other algorithms such as ngLOC and CELLO  also 
ranked mitochondrial localization to the top with possible 
cytoplasmic localization (Table 1). These are in accordance 
with the results demonstrating that the N-terminal prese-
quence can function as a mitochondrial import signal [15]. 
The subcellular localization of sGPX4 was predicted. 
The absence of the N-terminal presequence diminished the 
Table 1 in silico prediction of the subcellular localization of the long isoform of GPX4 (lGPX) using different algorithms. (ER: endoplasmic 
reticulum, ER-SP: endoplasmic reticulum – secretory pathway, mito: mitochondrion, extracell: extracellular space, cyto: cytoplasm, nuc: nucleus).
long isoform of GPX4 (lGPX4)
1st rank 2nd rank 3rd rank
TargetP 0.742 ER-SP 0.292 mito 0.013 other
Predotar 0.43 mito 0.37 other 0.35 ER
PSORT II 66.7 extracell 11.1 cyto 11.1 ER
ngLOC 34.6 mito 34.5 cyto 16.6 nuc
CELLO 1.55 extracell 1.44 mito 1.146 cyto
MitoProt 0.869 mito, no predictable cleavage site
iPSORT non-mitochondrial signal peptide, non-mitochondrial localization
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probability of import through the endoplasmic reticulum 
pathway as calculated by both the neural network-based 
algorithms TargetP, Predotar and rule-based algorithms 
CELLO, PSORT II (Table 2).
sGPX4 is considered to be mainly the cytoplasmic iso-
form which was supported by PSORT II and CELLO  the 
latter algorithm finding every feature of the peptide as 
cytoplasmic and both algorithms showing low probability 
of mitochondrial localization (Table 2).
However, Mitoprot and ngLOC algorithms show signif-
icant mitochondrial localization of sGPX4, with ngLOC 
showing mitochondrial localization being as probable as 
cytoplasmic (Table 2). Moreover, the multi-localized con-
fidence score (MLCS, if MLCS ≥ 60 multiple localization 
is calculated) predicted by ngLOC for sGPX4 was 69.74 
while for lGPX4 was 69.04.
Based on these results targeting of lGPX4 and sGPX4 to 
multiple organelles is possible as a number of rule- and neu-
ral network-based algorithms showed concordant results to 
specific pathways. As the overexpression of human sGPX4 
in transgenic mice showed that the elevated protein levels 
can be found in mitochondria [17], a non-canonical mito-
chondrial import pathway of sGPX4 is presumable.
Dual targeting of peptide sequences is possible through 
different mechanisms. It was shown in the example of 
GSTa4-4 (Glutathione S-transferase alpha 4-4) with a 
C-terminal mitochondrial targeting sequence which func-
tions as a switch between mitochondrial and cytoso-
lic localization dependent on the C-terminal phosphor-
ylation of specific serine and threonine residues [36]. In 
this case oxidative stress and kinase activity dependent 
hyper-phosphorylation leads to chaperon (Hsp70) binding 
which inhibits cytosolic homodimer formation and thus 
retains an import-competent form [36]. However this tar-
geting strategy of sGPX4 is not so possible as it was shown 
through X-ray crystallography that in physiological condi-
tions it is a functional monomer [37].
A similar mechanism of bimodal protein targeting 
to either endoplasmic reticulum or mitochondria was 
described for different CYP (Cytochrome P450 oxidase) 
isoforms lacking an N-terminal mitochondrial target-
ing sequence [38]. Dually targeted CYPs’ (e.g. CYP1A1, 
2B1, 2E1 and 2D6 [39]) are primarily processed through 
the SRP (signal recognition particle) pathway involving 
SRP-binding to the hydrophobic N-terminal of the nascent 
polipeptid and delivery to the ER through the translocon 
complex. However in this case the N-terminal sequence 
is a chimeric signal: the ER targeting region is flanked 
by a cryptic mitochondrial targeting sequence which can 
be activated by either proteolytic cleavage (family I., e.g. 
CYP1A1) or phosphorylation (family II., e.g. CYP2B1, 
2E1, 2D6) [39, 40]. The structure of the two families of 
chimeric signals show a slight difference: both contain 
the N-terminal ER targeting sequence which is followed 
by the mitochondrial signal and a proline rich region, but 
family I signals contain a proteolytic cleavage site just 
between the ER and mitochondrial targeting sequences, 
while family II chimeric sequences contain a downstream 
phosphorylation site (usually a serine residue) [39]. 
The mechanism of bimodal targeting is well studied at 
the level of specific CYP proteins where several sequence 
regions responsible of targeting have been identified. 
Since the N-terminal presequence lacking sGPX4 was 
found in multiple organelles and non-canonical import 
pathways are presumable we evaluated by the previously 
used in silico methods the localization of a chimeric signal 
containing peptide CYP2B1 as well as a solely mitochon-
drial targeted CYP27A1 (Table 3).
CYP27A1 contains a canonical N-terminal cleavable 
mitochondria targeting sequence [41] which was detected 
Table 2 in silico prediction of the subcellular localization of the short isoform of GPX4 (sGPX) using different algorithms. (ER: endoplasmic 
reticulum, ER-SP: endoplasmic reticulum – secretory pathway, mito: mitochondrion, extracell: extracellular space, cyto: cytoplasm, nuc: 
nucleus, cytoskel: cytoskeleton).
short isoform of GPX4 (sGPX4)
1st rank 2nd rank 3rd rank
TargetP 0.797 other 0.215 mito 0.048 ER-SP
Predotar 0.98 other 0.02 mito 0.01 ER
PSORT II 65.2 cyto 13.0 nuc 13.0 cytoskel
ngLOC 34.9 cyto 34.9 mito 18.0 nuc
CELLO 3.29 cyto 0.50 nuc 0.50 mito
MitoProt 0.5428 mito, no predictable cleavage site
iPSORT no signal peptide, non-mitochondrial localization
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by MitoProt and iPSORT as well (Table 3 CYP27A1). 
Nearly all algorithms (TargetP, MitoProt, Predotar, 
ngLOC and CELLO) predicted mitochondrial localiza-
tion with high probability with the exception of PSORT 
II which ranked cytoplasmic localization highest with 
mitochondrial being second highest (Table 3 CYP27A1). 
For CYP27A1 an MLCS score of 33.6 was calculated by 
ngLOC. These results indicated that the in silico methods 
could predict the localization of proteins with canonical 
mitochondrial signals reliably.
In the case of CYP2B1 containing chimeric signals 
- comprising an N-terminal ER import signal, a cryp-
tic mitochondrial targeting sequence and a phosphoryla-
tion site - the prediction efficiency of in silico algorithms 
was diverse (Table 3 CYP2B1). Most algorithms (TargetP, 
Predotar, PSORT II and ngLOC) predicted ER localization 
while CELLO differs by ranking plasma membrane local-
ization highest (Table 3 CYP2B1). MitoProt detected an 
N-terminal proteolytic cleavage site while iPSORT  found 
a targeting sequence based on the average  hydropathy, 
but was termed non-mitochondrial because of its’ average 
net charge and pattern (Table 3 CYP2B1). For CYP2B1 an 
MLCS score of 28.6 was calculated by ngLOC which sug-
gests that the algorithm was not able to detect the chimeric 
signal. Interestingly only CELLO ranked mitochondrial 
import with meaningful possibility based on the neigh-
boring sequence composition. 
As widely demonstrated in the literature ferroptosis 
could be induced by the inhibition or knock down of GPX4 
and also by the inhibition of the transport of its substrate, 
GSH [11]. The GSH supply plays critical role in enzyme 
activity and in the induction of ferroptosis. Thus beyond 
the localization of GPX4 the localization of the GSH trans-
porter protein SLC25A11 (2-oxoglutarate carrier:OGC) 
was also investigated by the aforementioned prediction 
tools. The prediction tool ngLOC that also uses gene ontol-
ogy analysis [31] gave high mitochondrial localization 
score and other three prediction tools (TargetP, MitoProt 
and CELLO) give moderate scores (Table 4). PSORT II 
gave a low probability while Predotar and iPSORT prac-
tically gave no probability of the mitochondrial localiza-
tion of SLC25A11 (Table 4). Interestingly Mitoprot found a 
mitochondrial cleavage site within the protein, but iPSORT 
could not detect any signal peptide, accordingly it predicted 
Table 3 in silico prediction of the subcellular localization of two different CYP450 enzymes with either canonical mitochondrial targeting (CYP27A1) 
or a non-canonical bimodal ER-mitochondrial chimeric signal (CYP2B1) using different algorithms. (ER: endoplasmic reticulum, ER-SP: endoplasmic 
reticulum – secretory pathway, mito: mitochondrion, cyto: cytoplasm, nuc: nucleus, lys: lysosome, perox: peroxisome, plasm: plasma membrane).
CYP27A1 CYP2B1
1st rank 2nd rank 3rd rank 1st rank 2nd rank 3rd rank
TargetP 0.931 mito 0.09 other 0.056 ER-SP 0.946 ER-SP 0.100 mito 0.017 other
Predotar 0.90 mito 0.09 other 0.02 ER-SP 0.99 ER 0.01 other 0.00 mito
PSORT II 47.8% cyto 21.7% mito 21.7% nuc 44.4 ER 22.2 lys 11.1 mito
ngLOC 53.23 mito 8.04 nuc 5.84 cyto 65.38 ER 5.62 plasm 4.89 nuc
CELLO 3.953 mito 0.448 perox 0.292 cyto 1.593 plasm 0.90 mito 0.59 lys
MitoProt 0.997 mito, cleavage site present 0.074 mito, cleavage site present
iPSORT mitochondrial targeting peptide, mitochondrial loc. non-mito signal peptide, non-mitochondrial loc.
Table 4 in silico prediction of the subcellular localization of SLC25A11 using different algorithms. (ER: endoplasmic reticulum, ER-SP: endoplasmic 
reticulum – secretory pathway, mito: mitochondrion, extracell: extracellular space, cyto: cytoplasm, nuc: nucleus, plasm: plasma membrane, perox: 
peroxisome).
SLC25A11
1st rank 2nd rank 3rd rank
TargetP 0.812 other 0.164 mito 0.079 ER-SP
Predotar 0.97 other 0.02 ER 0.00 mito
PSORT II 65.2 cyto 8.7 nuc 8.7 mito
ngLOC 61.5 mito 5.9 nuc 5.8 extracell
CELLO 2.51 plasm 1.08 mito 0.27 perox
MitoProt 0.116 mito, cleavage site present
iPSORT no signal peptide, non-mitochondrial localization
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non-mitochondrial localization (Table 4). At this point it is 
worth to have a look at the presumed mitochondrial GSH 
transporters. Although several previous studies have sug-
gested that the mitochondrial dicarboxylate (DIC) and 
2-oxoglutarate carriers were responsible for glutathione 
uptake [42-44] no transport of GSH by DIC and OGC was 
observed by using membrane vesicles of Lactococcus lac-
tis overexpressing these carriers [45]. However it should be 
noted that NSC34 neuronal cell line that stably overexpress 
OGC shows an increased mitochondrial GSH level [46]. 
This assumption was strengthened by a very recent study 
in which hepatocellular carcinoma cells (HCC) and liver 
explants from patients with hepatocellular carcinoma 
exhibit selective OGC upregulation, that contributes to 
mGSH maintenance [24] which contributes to cell death 
resistance by antagonizing mitochondrial outer membrane 
(MOM). Furthermore the silencing of OGC but not DIC 
reduces mitochondrial GSH (mGSH) levels and sensitized 
HCC cells to hypoxia-induced ROS generation. The silenc-
ing of OGC also resulted in cell death and impaired cell 
growth in three-dimensional multicellular HCC spheroids 
that were reversible upon mGSH replenishment [24] which 
contributes to cell death resistance by antagonizing mito-
chondrial outer membrane. All these in silico, in vitro and 
in vivo observations strengthen and underline the role of 
SLC25A11 in the mitochondrial GSH transport and the 
co-operation of SLC25A11 and support GPX4 mitochon-
drial localization in the avoidance of ferroptosis.
4 Conclusion
Ferroptosis is a novel cell death type that is induced by 
lipid peroxides [10]. Since the vast majority of ROS are 
generated by the mitochondrial electron transfer chain the 
involvement of mitochondria, mitochondrial ROS genera-
tion and ROS elimination in the ferroptotic pathway was 
assumed. The only key protein that was recognized up to 
date to have a role in ferroptosis is the lipid peroxide scav-
enger GPX4. The direct inhibition and the knock down of 
GPX4 or the depletion of its substrate GSH by the inhibi-
tion of GSH transport system lead to ferroptosis. Thus the 
subcellular localization of physiological relevant GPX4 iso-
forms (short, long and nuclear) and the localization of the 
only verified GSH transport protein SLC25A11 has been 
investigated by in silico tools. Special attention was paid to 
the possible mitochondrial context by in silico tools above 
all regarding mitochondrial localization. Number of rule- 
and neural network-based algorithms showed concordant 
results to specific pathways for both the long and short iso-
form of GPX4. Thus their targeting to multiple organelles 
is possible. Non-canonical import pathways are presumable 
for the short form therefore we also evaluated by using the 
same in silico methods the possible localization of a chi-
meric signal peptide present in CYP2B1 as well as a solely 
mitochondrial targeted CYP27A1. The chimeric signals of 
CYP2B1 includes an N-terminal ER import signal, a cryp-
tic mitochondrial targeting sequence and a phosphorylation 
site. The prediction efficiency of in silico algorithms in this 
case was diverse. Only CELLO could rank mitochondrial 
import with meaningful possibility based on the neigh-
boring sequence composition. For the GSH transporter 
SLC25A11 two of seven prediction tool gave high, three 
gave moderate mitochondrial localization possibility. These 
results support the assumption that SLC25A11 as the GSH 
supplier of GPX4 take part in the protection of mitochon-
dria against lipid peroxides. Summarily the possible co-op-
eration of SLC25A11 and GPX4 in the mitochondrion may 
play a role in the regulation of ferroptosis and strengthen 
the involvement of mitochondria in the ferroptotic pathway.
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